Objectives: Pasteurella multocida is an important zoonotic pathogen capable of causing a wide variety of human infections; therefore, it is a major public health problem worldwide. Antibiotics are still effective options for the treatment of P. multocida infections. Based on limited data on the global antibiotic susceptibility patterns of P. multocida-related human infections (PmHIs), in the present study, we carried out a systematic review and meta-analysis of this literature. Methods: We performed a systematic search across major databases, including Scopus, PubMed, and Web of Science, to identify relevant studies that evaluated the antibiotic susceptibility patterns of PmHI isolates. Critical appraisal was carried out by means of a Joanna Briggs Institute (JBI) checklist. All statistical analyses were conducted using the Comprehensive Meta-Analysis (CMA) software. The study protocol was prospectively registered (CRD42025644385). Results: A total of 11 studies investigated 304 PmHIs, which met our inclusion criteria. The pooled rates of sensitivity to tetracycline, cephalothin, penicillin, and ampicillin were: 96.7%, 95.7%, 94.2%, and 93%, respectively. However, the susceptibility rates to gentamicin, ciprofloxacin, sulfamethoxazole, doxycycline, chloramphenicol, and erythromycin were lower than 85%. Considerable data heterogeneity ( I 2 > 50%, p-value < 0.05) was observed to erythromycin, penicillin, gentamicin, sulfamethoxazole, ciprofloxacin, doxycycline, and cephalothin. The Begg’s tests did not indicate the publication bias ( p-value > 0.05), while the Egger’s tests showed some evidence of publication bias for tetracycline, penicillin, and ampicillin. Conclusions: Although this meta-analysis reported that the overall resistance of P. multocida to commonly prescribed antibiotics (i.e., tetracycline, cephalothin, penicillin, and ampicillin) is low; however, given the considerable heterogeneity among the studies, susceptibility testing prior to antibiotic choice is essential to avoid treatment failure.